The DOI matches its Crossref record; 154 of the 154 references it cites were found in a registry or an index.
Multifaceted roles of GSK-3 and Wnt/β-catenin in hematopoiesis and leukemogenesis: opportunities for therapeutic intervention
Open accessAbstract
Glycogen synthase kinase-3 (GSK-3) is well documented to participate in a complex array of critical cellular processes. It was initially identified in rat skeletal muscle as a serine/threonine kinase that phosphorylated and inactivated glycogen synthase. This versatile protein is involved in numerous signaling pathways that influence metabolism, embryogenesis, differentiation, migration, cell cycle progression and survival. Recently, GSK-3 has been implicated in leukemia stem cell pathophysiology and may be an appropriate target for its eradication. In this review, we will discuss the roles that GSK-3 plays in hematopoiesis and leukemogenesis as how this pivotal kinase can interact with multiple signaling pathways such as: Wnt/β-catenin, phosphoinositide 3-kinase (PI3K)/phosphatase and tensin homolog (PTEN)/Akt/mammalian target of rapamycin (mTOR), Ras/Raf/MEK/extracellular signal-regulated kinase (ERK), Notch and others. Moreover, we will discuss how targeting GSK-3 and these other pathways can improve leukemia therapy and may overcome therapeutic resistance. In summary, GSK-3 is a crucial regulatory kinase interacting with multiple pathways to control various physiological processes, as well as leukemia stem cells, leukemia progression and therapeutic resistance. GSK-3 and Wnt are clearly intriguing therapeutic targets.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wnt/β-catenin signaling and disease
Clevers, H., & Nusse, R. (2012) · Cell · doi:10.1016/j.cell.2012.05.012 · Cited by 5,554
Wnt proteins are lipid-modified and can act as stem cell growth factors
Willert, K., Brown, J. D., Danenberg, E., Duncan, A. W., Weissman, I. L., Reya, T., Yates, J. R., & Nusse, R. (2003) · Nature · doi:10.1038/nature01611 · Cited by 2,257
A role for Wnt signalling in self-renewal of haematopoietic stem cells
Reya, T., Duncan, A. W., Ailles, L., Domen, J., Scherer, D. C., Willert, K., Hintz, L., Nusse, R., & Weissman, I. L. (2003) · Nature · doi:10.1038/nature01593 · Cited by 2,159
Glycogen synthase kinase-3β regulates cyclin D1 proteolysis and subcellular localization
Diehl, J. A., Cheng, M., Roussel, M. F., & Sherr, C. J. (1998) · Genes & Development · doi:10.1101/gad.12.22.3499 · Cited by 2,130
Sato, N., Meijer, L., Skaltsounis, L., Greengard, P., & Brivanlou, A. H. (2004) · Nature Medicine · doi:10.1038/nm979 · Cited by 2,109
GSK-3: tricks of the trade for a multi-tasking kinase
Doble, B. W., & Woodgett, J. R. (2003) · Journal of Cell Science · doi:10.1242/jcs.00384 · Cited by 2,084
Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling
Huang, S.-M. A., Mishina, Y. M., Liu, S., Cheung, A., Stegmeier, F., Michaud, G. A., Charlat, O., Wiellette, E., Zhang, Y., Wiessner, S., et al. (2009) · Nature · doi:10.1038/nature08356 · Cited by 2,037
WNT signalling pathways as therapeutic targets in cancer
Anastas, J. N., & Moon, R. T. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3419 · Cited by 1,911
Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML
Jamieson, C. H. M., Ailles, L. E., Dylla, S. J., Muijtjens, M., Jones, C., Zehnder, J. L., Gotlib, J., Li, K., Manz, M. G., Keating, A., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040258 · Cited by 1,485
Small molecule–mediated disruption of Wnt-dependent signaling in tissue regeneration and cancer
Chen, B., Dodge, M. E., Tang, W., Lu, J., Ma, Z., Fan, C.-W., Wei, S., Hao, W., Kilgore, J., Williams, N. S., et al. (2009) · Nature Chemical Biology · doi:10.1038/nchembio.137 · Cited by 1,383
Inoki, K., Ouyang, H., Zhu, T., Lindvall, C., Wang, Y., Zhang, X., Yang, Q., Bennett, C., Harada, Y., Stankunas, K., et al. (2006) · Cell · doi:10.1016/j.cell.2006.06.055 · Cited by 1,377
Molecular cloning and expression of glycogen synthase kinase‐3/factor A.
Woodgett, J. R. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb07419.x · Cited by 1,362
Ikeda, S. (1998) · The EMBO Journal · doi:10.1093/emboj/17.5.1371 · Cited by 1,246
Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells
Yilmaz, Ö. H., Valdez, R., Theisen, B. K., Guo, W., Ferguson, D. O., Wu, H., & Morrison, S. J. (2006) · Nature · doi:10.1038/nature04703 · Cited by 1,113
Lustig, B., Jerchow, B., Sachs, M., Weiler, S., Pietsch, T., Karsten, U., van de Wetering, M., Clevers, H., Schlag, P. M., Birchmeier, W., et al. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.4.1184-1193.2002 · Cited by 1,036
Embi, N., Rylatt, D. B., & Cohen, P. (1980) · PubMed · Cited by 911
Prostaglandin E 2 Promotes Colon Cancer Cell Growth Through a G s -Axin-ß-Catenin Signaling Axis
Castellone, M. D., Teramoto, H., Williams, B. O., Druey, K. M., & Gutkind, J. S. (2005) · Science · doi:10.1126/science.1116221 · Cited by 883
A dual-kinase mechanism for Wnt co-receptor phosphorylation and activation
Zeng, X., Tamai, K., Doble, B., Li, S., Huang, H., Habas, R., Okamura, H., Woodgett, J., & He, X. (2005) · Nature · doi:10.1038/nature04185 · Cited by 849
EMBI, N., RYLATT, D. B., & COHEN, P. (1980) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1980.tb06059.x · Cited by 779
Integration of Notch and Wnt signaling in hematopoietic stem cell maintenance
Duncan, A. W., Rattis, F. M., DiMascio, L. N., Congdon, K. L., Pazianos, G., Zhao, C., Yoon, K., Cook, J. M., Willert, K., Gaiano, N., et al. (2005) · Nature Immunology · doi:10.1038/ni1164 · Cited by 771
The Wnt/β-Catenin Pathway Is Required for the Development of Leukemia Stem Cells in AML
Wang, Y., Krivtsov, A. V., Sinha, A. U., North, T. E., Goessling, W., Feng, Z., Zon, L. I., & Armstrong, S. A. (2010) · Science · doi:10.1126/science.1186624 · Cited by 763
A PML–PPAR-δ pathway for fatty acid oxidation regulates hematopoietic stem cell maintenance
Ito, K., Carracedo, A., Weiss, D., Arai, F., Ala, U., Avigan, D. E., Schafer, Z. T., Evans, R. M., Suda, T., Lee, C.-H., et al. (2012) · Nature Medicine · doi:10.1038/nm.2882 · Cited by 729
Chen, C., Liu, Y., Liu, R., Ikenoue, T., Guan, K.-L., Liu, Y., & Zheng, P. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20081297 · Cited by 682
Activation of the Wnt Signaling Pathway: A Molecular Mechanism for Lithium Action
Hedgepeth, C. M., Conrad, L. J., Zhang, J., Huang, H.-C., Lee, V. M. Y., & Klein, P. S. (1997) · Developmental Biology · doi:10.1006/dbio.1997.8552 · Cited by 636
Loss of β-Catenin Impairs the Renewal of Normal and CML Stem Cells In Vivo
Zhao, C., Blum, J., Chen, A., Kwon, H. Y., Jung, S. H., Cook, J. M., Lagoo, A., & Reya, T. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.11.003 · Cited by 592
Casein kinase 1 γ couples Wnt receptor activation to cytoplasmic signal transduction
Davidson, G., Wu, W., Shen, J., Bilic, J., Fenger, U., Stannek, P., Glinka, A., & Niehrs, C. (2005) · Nature · doi:10.1038/nature04170 · Cited by 581
DKK1, a negative regulator of Wnt signaling, is a target of the β-catenin/TCF pathway
Niida, A., Hiroko, T., Kasai, M., Furukawa, Y., Nakamura, Y., Suzuki, Y., Sugano, S., & Akiyama, T. (2004) · Oncogene · doi:10.1038/sj.onc.1207892 · Cited by 554
Chalecka-Franaszek, E., & Chuang, D.-M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.15.8745 · Cited by 542
PML targeting eradicates quiescent leukaemia-initiating cells
Ito, K., Bernardi, R., Morotti, A., Matsuoka, S., Saglio, G., Ikeda, Y., Rosenblatt, J., Avigan, D. E., Teruya-Feldstein, J., & Pandolfi, P. P. (2008) · Nature · doi:10.1038/nature07016 · Cited by 538
Phosphorylation by p38 MAPK as an Alternative Pathway for GSK3β Inactivation
Thornton, T. M., Pedraza-Alva, G., Deng, B., Wood, C. D., Aronshtam, A., Clements, J. L., Sabio, G., Davis, R. J., Matthews, D. E., Doble, B., et al. (2008) · Science · doi:10.1126/science.1156037 · Cited by 484
Embryonic stem cells require Wnt proteins to prevent differentiation to epiblast stem cells
ten Berge, D., Kurek, D., Blauwkamp, T., Koole, W., Maas, A., Eroglu, E., Siu, R. K., & Nusse, R. (2011) · Nature Cell Biology · doi:10.1038/ncb2314 · Cited by 468
Doble, B. W., Patel, S., Wood, G. A., Kockeritz, L. K., & Woodgett, J. R. (2007) · Developmental Cell · doi:10.1016/j.devcel.2007.04.001 · Cited by 448
Phosphoinositide 3-kinase and Akt are essential for Sonic Hedgehog signaling
Riobó, N. A., Lu, K., Ai, X., Haines, G. M., & Emerson, C. P. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504337103 · Cited by 439
Differential Regulation of Glycogen Synthase Kinase 3β by Insulin and Wnt Signaling
Ding, V. W., Chen, R.-H., & McCormick, F. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m005342200 · Cited by 427
Li, L., Wang, L., Li, L., Wang, Z., Ho, Y., McDonald, T., Holyoake, T. L., Chen, W., & Bhatia, R. (2012) · Cancer Cell · doi:10.1016/j.ccr.2011.12.020 · Cited by 410
Wilms Tumor Suppressor WTX Negatively Regulates WNT/ß-Catenin Signaling
Major, M. B., Camp, N. D., Berndt, J. D., Yi, X., Goldenberg, S. J., Hubbert, C., Biechele, T. L., Gingras, A.-C., Zheng, N., MacCoss, M. J., et al. (2007) · Science · doi:10.1126/science/1141515 · Cited by 405
Ding, Q., He, X., Hsu, J.-M., Xia, W., Chen, C.-T., Li, L.-Y., Lee, D.-F., Liu, J.-C., Zhong, Q., Wang, X., et al. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00620-06 · Cited by 393
The Lkb1 metabolic sensor maintains haematopoietic stem cell survival
Gurumurthy, S., Xie, S. Z., Alagesan, B., Kim, J., Yusuf, R. Z., Saez, B., Tzatsos, A., Ozsolak, F., Milos, P., Ferrari, F., et al. (2010) · Nature · doi:10.1038/nature09572 · Cited by 391
NUMB controls p53 tumour suppressor activity
Colaluca, I. N., Tosoni, D., Nuciforo, P., Senic-Matuglia, F., Galimberti, V., Viale, G., Pece, S., & Di Fiore, P. P. (2008) · Nature · doi:10.1038/nature06412 · Cited by 385
Bhat, R. V., Shanley, J., Correll, M. P., Fieles, W. E., Keith, R. A., Scott, C. W., & Lee, C.-M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.190297597 · Cited by 366
Multisite Phosphorylation by Cdk2 and GSK3 Controls Cyclin E Degradation
Welcker, M., Singer, J., Loeb, K. R., Grim, J., Bloecher, A., Gurien-West, M., Clurman, B. E., & Roberts, J. M. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00287-9 · Cited by 363
Regulation of myeloid leukaemia by the cell-fate determinant Musashi
Ito, T., Kwon, H. Y., Zimdahl, B., Congdon, K. L., Blum, J., Lento, W. E., Zhao, C., Lagoo, A., Gerrard, G., Foroni, L., et al. (2010) · Nature · doi:10.1038/nature09171 · Cited by 355
Role of Glycogen Synthase Kinase-3β in Cardioprotection
Juhaszova, M., Zorov, D. B., Yaniv, Y., Nuss, H. B., Wang, S., & Sollott, S. J. (2009) · Circulation Research · doi:10.1161/circresaha.109.197996 · Cited by 352
What Are the bona fide GSK3 Substrates?
Sutherland, C. (2011) · International Journal of Alzheimer’s Disease · doi:10.4061/2011/505607 · Cited by 345
Espinosa, L., Inglés-Esteve, J., Aguilera, C., & Bigas, A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304001200 · Cited by 337
Dishevelled 2 Recruits ß-Arrestin 2 to Mediate Wnt5A-Stimulated Endocytosis of Frizzled 4
Chen, W., ten Berge, D., Brown, J., Ahn, S., Hu, L. A., Miller, W. E., Caron, M. G., Barak, L. S., Nusse, R., & Lefkowitz, R. J. (2003) · Science · doi:10.1126/science.1082808 · Cited by 334
Wnt5a inhibits B cell proliferation and functions as a tumor suppressor in hematopoietic tissue
Liang, H., Chen, Q., Coles, A. H., Anderson, S. J., Pihan, G., Bradley, A., Gerstein, R., Jurecic, R., & Jones, S. N. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00268-x · Cited by 329
COLE, A., FRAME, S., & COHEN, P. (2004) · Biochemical Journal · doi:10.1042/bj20031259 · Cited by 324
Glycogen Synthase Kinase 3α-Specific Regulation of Murine Hepatic Glycogen Metabolism
MacAulay, K., Doble, B. W., Patel, S., Hansotia, T., Sinclair, E. M., Drucker, D. J., Nagy, A., & Woodgett, J. R. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.08.013 · Cited by 299
Glycogen Synthase Kinase-3 - An Overview of An Over-Achieving Protein Kinase
Kockeritz, L., Doble, B., Patel, S., & Woodgett, J. (2006) · Current Drug Targets · doi:10.2174/1389450110607011377 · Cited by 284
Dysregulated gene expression networks in human acute myelogenous leukemia stem cells
Majeti, R., Becker, M. W., Tian, Q., Lee, T.-L. M., Yan, X., Liu, R., Chiang, J.-H., Hood, L., Clarke, M. F., & Weissman, I. L. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0900089106 · Cited by 281
β-Catenin Mediates the Establishment and Drug Resistance of MLL Leukemic Stem Cells
Yeung, J., Esposito, M. T., Gandillet, A., Zeisig, B. B., Griessinger, E., Bonnet, D., & So, C. W. E. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.10.032 · Cited by 270
Glycogen synthase kinase 3 in MLL leukaemia maintenance and targeted therapy
Wang, Z., Smith, K. S., Murphy, M., Piloto, O., Somervaille, T. C. P., & Cleary, M. L. (2008) · Nature · doi:10.1038/nature07284 · Cited by 265
Roles of the Ras/Raf/MEK/ERK pathway in leukemia therapy
Steelman, L. S., Franklin, R. A., Abrams, S. L., Chappell, W., Kempf, C. R., Bäsecke, J., Stivala, F., Donia, M., Fagone, P., Nicoletti, F., et al. (2011) · Leukemia · doi:10.1038/leu.2011.66 · Cited by 261
Self-citationWnt-5a has tumor suppressor activity in thyroid carcinoma
Kremenevskaja, N., von Wasielewski, R., Rao, A. S., Schöfl, C., Andersson, T., & Brabant, G. (2005) · Oncogene · doi:10.1038/sj.onc.1208370 · Cited by 260
AKT/FOXO Signaling Enforces Reversible Differentiation Blockade in Myeloid Leukemias
Sykes, S. M., Lane, S. W., Bullinger, L., Kalaitzidis, D., Yusuf, R., Saez, B., Ferraro, F., Mercier, F., Singh, H., Brumme, K. M., et al. (2011) · Cell · doi:10.1016/j.cell.2011.07.032 · Cited by 257
The Wnt/β-catenin pathway regulates growth and maintenance of colonospheres
Kanwar, S. S., Yu, Y., Nautiyal, J., Patel, B. B., & Majumdar, A. P. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-212 · Cited by 253
Glycogen synthase kinase 3β missplicing contributes to leukemia stem cell generation
Abrahamsson, A. E., Geron, I., Gotlib, J., Dao, K.-H. T., Barroga, C. F., Newton, I. G., Giles, F. J., Durocher, J., Creusot, R. S., Karimi, M., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0900189106 · Cited by 246
Lesort, M., Jope, R. S., & Johnson, G. V. W. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0720576.x · Cited by 240
Heidel, F. H., Bullinger, L., Feng, Z., Wang, Z., Neff, T. A., Stein, L., Kalaitzidis, D., Lane, S. W., & Armstrong, S. A. (2012) · Cell Stem Cell · doi:10.1016/j.stem.2012.02.017 · Cited by 225
Glycogen Synthase Kinase-3 Couples AKT-dependent Signaling to the Regulation of p21Cip1 Degradation
Rössig, L., Badorff, C., Holzmann, Y., Zeiher, A. M., & Dimmeler, S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m106157200 · Cited by 218
Bcr‐Abl stabilizes β‐catenin in chronic myeloid leukemia through its tyrosine phosphorylation
Coluccia, A. M. L., Vacca, A., Duñach, M., Mologni, L., Redaelli, S., Bustos, V. H., Benati, D., Pinna, L. A., & Gambacorti‐Passerini, C. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601485 · Cited by 217
Maintenance of hematopoietic stem cells through regulation of Wnt and mTOR pathways
Huang, J., Nguyen-McCarty, M., Hexner, E. O., Danet-Desnoyers, G., & Klein, P. S. (2012) · Nature Medicine · doi:10.1038/nm.2984 · Cited by 215
Long-term, multilineage hematopoiesis occurs in the combined absence of β-catenin and γ-catenin
Jeannet, G., Scheller, M., Scarpellino, L., Duboux, S., Gardiol, N., Back, J., Kuttler, F., Malanchi, I., Birchmeier, W., Leutz, A., et al. (2008) · Blood · doi:10.1182/blood-2007-07-102558 · Cited by 215
Luis, T. C., Ichii, M., Brugman, M. H., Kincade, P., & Staal, F. J. T. (2012) · Leukemia · doi:10.1038/leu.2011.387 · Cited by 208
Martelli, A. M., Evangelisti, C., Chappell, W., Abrams, S. L., Bäsecke, J., Stivala, F., Donia, M., Fagone, P., Nicoletti, F., Libra, M., et al. (2011) · Leukemia · doi:10.1038/leu.2011.46 · Cited by 204
Self-citationProapoptotic Stimuli Induce Nuclear Accumulation of Glycogen Synthase Kinase-3β
Bijur, G. N., & Jope, R. S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105725200 · Cited by 204
Glycogen Synthase Kinase 3 Is an Insulin-Regulated C/EBPα Kinase
Ross, S. E., Erickson, R. L., Hemati, N., & MacDougald, O. A. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.12.8433 · Cited by 197
Zhao, Y., Altman, B. J., Coloff, J. L., Herman, C. E., Jacobs, S. R., Wieman, H. L., Wofford, J. A., Dimascio, L. N., Ilkayeva, O., Kelekar, A., et al. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00153-07 · Cited by 193
Glycogen synthase kinase 3 beta: can it be a target for oral cancer
Mishra, R. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-144 · Cited by 190
Schwarz-Romond, T., Asbrand, C., Bakkers, J., Kühl, M., Schaeffer, H.-J., Huelsken, J., Behrens, J., Hammerschmidt, M., & Birchmeier, W. (2002) · Genes & Development · doi:10.1101/gad.230402 · Cited by 189
Rao, E., Jiang, C., Ji, M., Huang, X., Iqbal, J., Lenz, G., Wright, G., Staudt, L. M., Zhao, Y., McKeithan, T. W., et al. (2012) · Leukemia · doi:10.1038/leu.2011.305 · Cited by 188
Ougolkov, A. V., Bone, N. D., Fernandez-Zapico, M. E., Kay, N. E., & Billadeau, D. D. (2007) · Blood · doi:10.1182/blood-2006-12-060947 · Cited by 187
Lee, J. Y., Nakada, D., Yilmaz, O. H., Tothova, Z., Joseph, N. M., Lim, M. S., Gilliland, D. G., & Morrison, S. J. (2010) · Cell Stem Cell · doi:10.1016/j.stem.2010.09.015 · Cited by 185
Bennecib, M., Gong, C.-X., Grundke-Iqbal, I., & Iqbal, K. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)02203-1 · Cited by 184
Abnormalities in brain structure and behavior in GSK-3alpha mutant mice
Kaidanovich-Beilin, O., Lipina, T. V., Takao, K., van Eede, M., Hattori, S., Laliberté, C., Khan, M., Okamoto, K., Chambers, J. W., Fletcher, P. J., et al. (2009) · Molecular Brain · doi:10.1186/1756-6606-2-35 · Cited by 177
WNT7A Regulates Tumor Growth and Progression in Ovarian Cancer through the WNT/β-Catenin Pathway
Yoshioka, S., King, M. L., Ran, S., Okuda, H., MacLean, J. A., McAsey, M. E., Sugino, N., Brard, L., Watabe, K., & Hayashi, K. (2012) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-11-0177 · Cited by 169
Fbxw7α- and GSK3-mediated degradation of p100 is a pro-survival mechanism in multiple myeloma
Busino, L., Millman, S. E., Scotto, L., Kyratsous, C. A., Basrur, V., O’Connor, O., Hoffmann, A., Elenitoba-Johnson, K. S., & Pagano, M. (2012) · Nature Cell Biology · doi:10.1038/ncb2463 · Cited by 167
Shin, S., Wolgamott, L., Yu, Y., Blenis, J., & Yoon, S.-O. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1110195108 · Cited by 165
Gao, C., Hölscher, C., Liu, Y., & Li, L. (2012) · revneuro · doi:10.1515/rns.2011.061 · Cited by 164
The dual mTORC1 and mTORC2 inhibitor AZD8055 has anti-tumor activity in acute myeloid leukemia
Willems, L., Chapuis, N., Puissant, A., Maciel, T. T., Green, A. S., Jacque, N., Vignon, C., Park, S., Guichard, S., Herault, O., et al. (2012) · Leukemia · doi:10.1038/leu.2011.339 · Cited by 159
NUMB-ing down cancer by more than just a NOTCH
Pece, S., Confalonieri, S., Romano, P. R., & Fiore, P. P. D. (2010) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2010.10.001 · Cited by 155
Wnt Inhibitor Screen Reveals Iron Dependence of β-Catenin Signaling in Cancers
Song, S., Christova, T. Y., Perusini, S. J., Alizadeh, S., Bao, R.-Y., Miller, B. W., Hurren, R., Jitkova, Y., Gronda, M., Isaac, M. B., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-2745 · Cited by 152
The evolutionarily conserved porcupine gene family is involved in the processing of the Wnt family
Tanaka, K., Okabayashi, K., Asashima, M., Perrimon, N., & Kadowaki, T. (2000) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2000.01478.x · Cited by 149
Pivotal role for glycogen synthase kinase–3 in hematopoietic stem cell homeostasis in mice
Huang, J. Y., Zhang, Y., Bersenev, A., O’Brien, W. T., Tong, W., Emerson, S. G., & Klein, P. S. (2009) · Journal of Clinical Investigation · doi:10.1172/jci40572 · Cited by 143
Evidence that glycogen synthase kinase‐3 isoforms have distinct substrate preference in the brain
Soutar, M. P. M., Kim, W.-Y., Williamson, R., Peggie, M. W., Hastie, C. J., McLauchlan, H., Snider, W. D., Gordon‐Weeks, P. R., & Sutherland, C. D. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06988.x · Cited by 139
Silva, A., Gírio, A., Cebola, I., Santos, C. I., Antunes, F., & Barata, J. T. (2011) · Leukemia · doi:10.1038/leu.2011.56 · Cited by 135
Bakre, M. M., Hoi, A., Mong, J. C. Y., Koh, Y. Y., Wong, K., & Stanton, L. W. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m704287200 · Cited by 134
Cyclooxygenase-2 Inhibition Inhibits c-Met Kinase Activity and Wnt Activity in Colon Cancer
Tuynman, J. B., Vermeulen, L., Boon, E. M. J., Kemper, K., Zwinderman, A. H., Peppelenbosch, M. P., & Richel, D. J. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5172 · Cited by 134
GSK-3-Mediated Phosphorylation Enhances Maf-Transforming Activity
Rocques, N., Zeid, N. A., Sii-Felice, K., Lecoin, L., Felder‐Schmittbuhl, M., Eychène, A., & Pouponnot, C. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.11.009 · Cited by 132
O’Brien, W. T., Huang, J. Y., Buccafusca, R., Garskof, J., Valvezan, A. J., Berry, G. T., & Klein, P. S. (2011) · Journal of Clinical Investigation · doi:10.1172/jci45194 · Cited by 123
SIRT1 regulates Dishevelled proteins and promotes transient and constitutive Wnt signaling
Holloway, K. R., Calhoun, T. N., Saxena, M., Metoyer, C. F., Kandler, E. F., Rivera, C. A., & Pruitt, K. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0911325107 · Cited by 123
Notch signaling in mammalian hematopoietic stem cells
Pajcini, K. V., Speck, N. A., & Pear, W. S. (2011) · Leukemia · doi:10.1038/leu.2011.127 · Cited by 122
Liu, P., Xu, B., Shen, W., Zhu, H., Wu, W., Fu, Y., Chen, H., Dong, H., Zhu, Y., Miao, K., et al. (2011) · Leukemia · doi:10.1038/leu.2011.357 · Cited by 120
Glycogen synthase kinase 3β is tyrosine phosphorylated by PYK2
Hartigan, J. A., Xiong, W.-C., & Johnson, G. V. W. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.4986 · Cited by 117
Yuan, H., Mao, J., Li, L., & Wu, D. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.43.30419 · Cited by 116
Bianchi, M., Lucchini, S. D., Marin, O., Turner, D. L., Hanks, S. K., & Villa-Moruzzi, E. (2005) · Biochemical Journal · doi:10.1042/bj20050282 · Cited by 114
Gu, Y., Chen, T., Meng, Z., Gan, Y., Xu, X., Lou, G., Li, H., Gan, X., Zhou, H., Tang, J., et al. (2012) · Blood · doi:10.1182/blood-2012-06-434894 · Cited by 110
Wang, H., Brown, J. R., Gu, Z., Garcia, C. A., Liang, R., Alard, P., Beurel, E., Jope, R. S., Greenway, T., & Martin, M. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1002513 · Cited by 110
The serine/threonine kinase Pim-2 is a novel anti-apoptotic mediator in myeloma cells
Asano, J., Nakano, A., Oda, A., Amou, H., Hiasa, M., Takeuchi, K., Miki, H., Nakamura, S., Harada, T., Fujii, S., et al. (2011) · Leukemia · doi:10.1038/leu.2011.60 · Cited by 109
Wnt5a Suppresses Epithelial Ovarian Cancer by Promoting Cellular Senescence
Bitler, B. G., Nicodemus, J. P., Li, H., Cai, Q. K., Wu, H. G., Xiang, H., Li, T., Birrer, M. J., Godwin, A. K., Cairns, P., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-1341 · Cited by 108
Glycogen Synthase Kinase-3 and Cancer: Good Cop, Bad Cop?
Patel, S., & Woodgett, J. R. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.10.013 · Cited by 107
Banerji, V., Frumm, S. M., Ross, K. N., Li, L. S., Schinzel, A. C., Hahn, C. K., Kakoza, R. M., Chow, K. T., Ross, L., Alexe, G., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci46465 · Cited by 105
Grimaldi, C., Chiarini, F., Tabellini, G., Ricci, F., Tazzari, P. L., Battistelli, M., Falcieri, E., Bortul, R., Melchionda, F., Iacobucci, I., et al. (2011) · Leukemia · doi:10.1038/leu.2011.269 · Cited by 104
Self-citationEvangelisti, C., Ricci, F., Tazzari, P. L., Tabellini, G., Battistelli, M., Falcieri, E., Chiarini, F., Bortul, R., Melchionda, F., Pagliaro, P., et al. (2011) · Leukemia · doi:10.1038/leu.2011.20 · Cited by 104
Self-citationValvezan, A. J., Zhang, F., Diehl, J. A., & Klein, P. S. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.323337 · Cited by 100
Acquired Radioresistance of Cancer and the AKT/GSK3β/cyclin D1 Overexpression Cycle
Shimura, T. (2011) · Journal of Radiation Research · doi:10.1269/jrr.11098 · Cited by 97
Cytotoxic activity of the novel Akt inhibitor, MK-2206, in T-cell acute lymphoblastic leukemia
Simioni, C., Neri, L. M., Tabellini, G., Ricci, F., Bressanin, D., Chiarini, F., Evangelisti, C., Cani, A., Tazzari, P. L., Melchionda, F., et al. (2012) · Leukemia · doi:10.1038/leu.2012.136 · Cited by 91
Self-citationThe Regulation of Glycogen Synthase Kinase-3 Nuclear Export by Frat/GBP
Franca‐Koh, J., Yeo, M., Fraser, E., Young, N., & Dale, T. C. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m207265200 · Cited by 88
t-Darpp Promotes Cancer Cell Survival by Up-regulation of Bcl2 through Akt-Dependent Mechanism
Belkhiri, A., Dar, A. A., Zaika, A. I., Kelley, M., & El-Rifai, W. M. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-1580 · Cited by 86
Wang, R., Xia, L., Gabrilove, J., Waxman, S., & Jing, Y. (2013) · Leukemia · doi:10.1038/leu.2012.180 · Cited by 85
Blackburn, J. S., Liu, S., Raiser, D. M., Martinez, S. A., Feng, H., Meeker, N. D., Gentry, J., Neuberg, D. S., Look, A. T., Ramaswamy, S., et al. (2012) · Leukemia · doi:10.1038/leu.2012.116 · Cited by 85
Schwarzer, R., Dörken, B., & Jundt, F. (2011) · Leukemia · doi:10.1038/leu.2011.265 · Cited by 85
Ramakrishnan, V. G., Ansell, S. M., Haug, J., Grote, D. M., Kimlinger, T. K., Stenson, M. J., Timm, M., Wellik, L. E., Halling, T. M., Rajkumar, S. V., et al. (2011) · Leukemia · doi:10.1038/leu.2011.192 · Cited by 78
PI3K/mTOR inhibition upregulates NOTCH-MYC signalling leading to an impaired cytotoxic response
Shepherd, C., Banerjee, L., Cheung, C. W., Mansour, M. R., Jenkinson, S., Gale, R. E., & Khwaja, A. (2012) · Leukemia · doi:10.1038/leu.2012.285 · Cited by 76
The Medicinal Chemistry of Novel Iron Chelators for the Treatment of Cancer
Kovačević, Ž., Kalinowski, D. S., Lovejoy, D. B., Yu, Y., Rahmanto, Y. S., Sharpe, P. C., Bernhardt, P. V., & Richardson, D. R. (2011) · Current Topics in Medicinal Chemistry · doi:10.2174/156802611794785190 · Cited by 74
Wu, Q., Zierold, C., & Ranheim, E. A. (2009) · Blood · doi:10.1182/blood-2008-06-163303 · Cited by 73
Context-dependent regulation of Musashi-mediated mRNA translation and cell cycle regulation.
MacNicol, M. C., Cragle, C. E., & MacNicol, A. M. (2011) · Cell Cycle · doi:10.4161/cc.10.1.14388 · Cited by 70
The controversial role of the Hedgehog pathway in normal and malignant hematopoiesis
Mar, B. G., Amakye, D. D., Aifantis, I., & Buonamici, S. (2011) · Leukemia · doi:10.1038/leu.2011.143 · Cited by 69
Bolzoni, M., Donofrío, G., Storti, P., Guasco, D., Toscani, D., Lazzaretti, M., Bonomini, S., Agnelli, L., Capocefalo, A., Palma, B. D., et al. (2012) · Leukemia · doi:10.1038/leu.2012.190 · Cited by 69
Bone, H. K., Damiano, T., Bartlett, S. T., Perry, A., Letchford, J., Sanchez-Ripoll, Y., Nelson, A. S., & Welham, M. J. (2009) · Chemistry & Biology · doi:10.1016/j.chembiol.2008.11.003 · Cited by 66
Yamamoto, K., Nakamura, Y., Nakamura, Y., Saito, K., & Furusawa, S. (2000) · British Journal of Haematology · doi:10.1046/j.1365-2141.2000.02003.x · Cited by 66
Fuka, G., Kantner, H.-P., Grausenburger, R., Inthal, A., Bauer, E., Krapf, G., Kaindl, U., Kauer, M., Dworzak, M. N., Stoiber, D., et al. (2011) · Leukemia · doi:10.1038/leu.2011.322 · Cited by 63
Glycogen Synthase Kinase-3β Mutagenesis Identifies a Common Binding Domain for GBP and Axin
Ferkey, D. M., & Kimelman, D. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m112363200 · Cited by 61
Morgan, G., Pearn, L., Liddiard, K., Pumford, S. L., Burnett, A. K., Tonks, A., & Darley, R. L. (2012) · Leukemia · doi:10.1038/leu.2012.221 · Cited by 60
Wickremasinghe, R. G., Prentice, A., & Steele, A. J. (2011) · Leukemia · doi:10.1038/leu.2011.103 · Cited by 60
Reddiconto, G., Toto, C., Palamà, I. E., Leo, S. D., de Luca, E., Matteis, S. D., Dini, L., Gambacorti-Passerini, C. B., Renzo, N. D., Maffia, M., et al. (2012) · Blood · doi:10.1182/blood-2011-06-361261 · Cited by 56
GSK3β inactivation induces apoptosis of leukemia cells by repressing the function of c-Myb
Zhou, F., Zhang, L., van Laar, T., van Dam, H., & ten Dijke, P. (2011) · Molecular Biology of the Cell · doi:10.1091/mbc.e11-06-0483 · Cited by 55
Xu, S., Evans, H., Buckle, C., Veirman, K. D., Hu, J., Xu, D., Menu, E., Becker, A. D., Broek, I. V., Leleu, X. P., et al. (2012) · Leukemia · doi:10.1038/leu.2012.126 · Cited by 55
β-Arrestin2 mediates the initiation and progression of myeloid leukemia
Fereshteh, M., Ito, T., Kovacs, J. J., Zhao, C., Kwon, H. Y., Tornini, V. A., Konuma, T., Chen, M., Lefkowitz, R. J., & Reya, T. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1209815109 · Cited by 55
Heterogeneous sensitivity of human acute myeloid leukemia to β-catenin down-modulation
Gandillet, A., Park, S., Lassailly, F., Griessinger, E., Vargaftig, J., Filby, A. J., Lister, T. A., & Bonnet, D. A. (2011) · Leukemia · doi:10.1038/leu.2011.17 · Cited by 54
Notch3-mediated regulation of MKP-1 levels promotes survival of T acute lymphoblastic leukemia cells
Masiero, M., Minuzzo, S. A., Pusceddu, I., Moserle, L., Persano, L., Agnusdei, V., Tosello, V., Basso, G., Amadori, A., & Indraccolo, S. (2011) · Leukemia · doi:10.1038/leu.2010.323 · Cited by 53
Nifoussi, S. K., Vrana, J. A., Domina, A. M., Biasio, A. D., Gui, J., Gregory, M. A., Hann, S., & Craig, R. W. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047060 · Cited by 53
GSK3 is a regulator of RAR-mediated differentiation
Gupta, K., Gulen, F., Sun, L., Aguilera, R., Chakrabarti, A., Kiselar, J., Agarwal, M. K., & Wald, D. N. (2012) · Leukemia · doi:10.1038/leu.2012.2 · Cited by 50
Xu, D., Hu, J., Xu, S., Bruyne, E. D., Menu, E., Camp, B. V., Vanderkerken, K., & Valckenborgh, E. V. (2011) · Leukemia · doi:10.1038/leu.2011.332 · Cited by 50
Alao, J. P., Stavropoulou, A. V., Lam, E. W. ‐., & Coombes, R. C. (2006) · Molecular Cancer · doi:10.1186/1476-4598-5-40 · Cited by 49
Increased number of peripheral blood CD34 + cells in lithium‐treated patients
Ballin, A., Lehman, D., Sirota, P., Litvinjuk, U., & Meytes, D. (1998) · British Journal of Haematology · doi:10.1046/j.1365-2141.1998.00537.x · Cited by 48
Involvement of the Syk–mTOR pathway in follicular lymphoma cell invasion and angiogenesis
Fruchon, S., Kheirallah, S., Saati, T. A., Ysebaert, L., Laurent, C., Leseux, L., Fournié, J., Laurent, G., & Bezombes, C. (2011) · Leukemia · doi:10.1038/leu.2011.248 · Cited by 47
Welham, M. J., Kingham, E., Sanchez-Ripoll, Y., Kumpfmueller, B., Storm, M. P., & Bone, H. K. (2011) · Biochemical Society Transactions · doi:10.1042/bst0390674 · Cited by 47
Kawazoe, H., Bilim, V. N., Ugolkov, A. V., Yuuki, K., Naito, S., Nagaoka, A., Kato, T., & Tomita, Y. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.05.147 · Cited by 46
Glycogen Synthase Kinase-3 regulates multiple myeloma cell growth and bortezomib-induced cell death
Piazza, F., Manni, S., Tubi, L. Q., Montini, B., Pavan, L., Colpo, A., Gnoato, M., Cabrelle, A., Adami, F., Zambello, R., et al. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-526 · Cited by 43
Regulation of myeloma cell growth through Akt/Gsk3/forkhead signaling pathway
G-Amlak, M., Shahab Uddin, M. S., Mahmud, D. L., Damacela, I., Lavelle, D., Ahmed, M., van Besien, K., & Wickrema, A. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)02278-7 · Cited by 41
Mirlashari, M. R., Randen, I., & Kjeldsen‐Kragh, J. (2011) · Leukemia Research · doi:10.1016/j.leukres.2011.11.013 · Cited by 39
Fu, Y., Hu, D., Qiu, J. G., Xie, X., Ye, F., & Lü, W. (2011) · International Journal of Gynecological Cancer · doi:10.1097/igc.0b013e31820d7366 · Cited by 39
Gunn, W., Krause, U., Lee, N., & Gregory, C. A. (2010) · Blood · doi:10.1182/blood-2010-09-308171 · Cited by 39
Coppernolle, S. V., Vanhee, S., Verstichel, G., Snauwaert, S., van der Spek, A., Velghe, I., Sinnesael, M., Heemskerk, M. H. M., Taghon, T., Leclercq, G., et al. (2011) · Leukemia · doi:10.1038/leu.2011.324 · Cited by 33
Inhibition of Glycogen Synthase Kinase-3
Ougolkov, A. V., & Billadeau, D. D. (2008) · Methods in molecular biology · doi:10.1007/978-1-59745-249-6_5 · Cited by 31
Si, J., Mueller, L., & Collins, S. J. (2011) · Leukemia · doi:10.1038/leu.2011.171 · Cited by 30
Ikegame, A., Ozaki, S., Tsuji, D., Harada, T., Fujii, S., Nakamura, S., Miki, H., Nakano, A., Kagawa, K., Takeuchi, K., et al. (2012) · Leukemia · doi:10.1038/leu.2012.78 · Cited by 30
Ochoa-Hernández, A. B., Ramos‐Solano, M., Meza‐Canales, I. D., García‐Castro, B., Reynoso, M. A. R., Rosales-Aviña, J. A., Barrera‐Chairez, E., Ortiz‐Lazareno, P. C., Hernández‐Flores, G., Bravo‐Cuéllar, A., et al. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-60 · Cited by 22
Stengel, C., Cheung, C. W., Quinn, J., Yong, K., & Khwaja, A. (2012) · Leukemia · doi:10.1038/leu.2012.69 · Cited by 22
Involvement of Glycogen Synthase Kinase-3β in Arsenic Trioxide–Induced p21 Expression
Huang, H., Liu, Z., & Cheng, Y.-L. (2011) · Toxicological Sciences · doi:10.1093/toxsci/kfr023 · Cited by 17
The Mck1 GSK-3 kinase inhibits the activity of Clb2-Cdk1 post-nuclear division
McQueen, J., van Dyk, D., Young, B. P., Loewen, C., & Measday, V. (2012) · Cell Cycle · doi:10.4161/cc.21731 · Cited by 12
Stein, R. S., Vogler, W. R., & Lefante, J. J. (1984) · American Journal of Clinical Oncology · doi:10.1097/00000421-198408000-00014 · Cited by 10
Cited by
Glycogen synthase kinase-3 (GSK3): Regulation, actions, and diseases
Beurel, E., Grieco, S. F., & Jope, R. S. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.11.016 · Cited by 1,768
GSK-3 as potential target for therapeutic intervention in cancer
McCubrey, J. A., Steelman, L. S., Bertrand, F. E., Davis, N. M., Sokolosky, M., Abrams, S. L., Montalto, G., D’Assoro, A. B., Libra, M., Nicoletti, F., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.2037 · Cited by 508
Self-citationAMPK/FIS1-Mediated Mitophagy Is Required for Self-Renewal of Human AML Stem Cells
Pei, S., Minhajuddin, M., Adane, B., Khan, N., Stevens, B. M., Mack, S. C., Lai, S., Rich, J. N., Inguva, A., Shannon, K. M., et al. (2018) · Cell Stem Cell · doi:10.1016/j.stem.2018.05.021 · Cited by 301
Wang, L., Li, J., & Di, L. (2022) · Medicinal Research Reviews · doi:10.1002/med.21867 · Cited by 261
Exercise Training Modulates Adipokine Dysregulations in Metabolic Syndrome
Babaei, P., & Hoseini, R. (2022) · Sports Medicine and Health Science · doi:10.1016/j.smhs.2022.01.001 · Cited by 52
Metadata
- Authors
- McCubrey, J. A., Steelman, L. S., Bertrand, F. E., Davis, N. M., Abrams, S. L., Montalto, G., D'Assoro, A. B., Libra, M., Nicoletti, F., Maestro, R., Basecke, J., Cocco, L., Cervello, M., & Martelli, A. M.
- Venue
- Leukemia
- Published
- 2013-06-19
- Volume
- 28
- Issue
- 1
- Pages
- 15-33
- ISSN
- 0887-6924 (ISSN-L)
- 1476-5551
- OpenAlex
- W1999876234
- Cited by
- 255
- References
- 154
- FWCI
- 8.47
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.